Cushing syndrome and Cushing disease: Pathology review

Last updated: September 10, 2025

Cushing syndrome and Cushing disease: Pathology review

Watch later

Watch later

Somatostatin
Synthesis of adrenocortical hormones
Cortisol
Testosterone
Estrogen and progesterone
Phosphate, calcium and magnesium homeostasis
Parathyroid hormone
Vitamin D
Calcitonin
Congenital adrenal hyperplasia
Primary adrenal insufficiency
Waterhouse-Friderichsen syndrome
Hyperaldosteronism
Adrenal cortical carcinoma
Cushing syndrome
Conn syndrome
Thyroglossal duct cyst
Hyperthyroidism
Graves disease
Thyroid eye disease (NORD)
Toxic multinodular goiter
Thyroid storm
Hypothyroidism
Euthyroid sick syndrome
Hashimoto thyroiditis
Subacute granulomatous thyroiditis
Riedel thyroiditis
Thyroid cancer
Hyperparathyroidism
Hypoparathyroidism
Hypercalcemia
Hypocalcemia
Diabetes mellitus
Diabetic retinopathy
Diabetic nephropathy
Hyperpituitarism
Pituitary adenoma
Hyperprolactinemia
Prolactinoma
Gigantism
Acromegaly
Hypopituitarism
Pituitary apoplexy
Sheehan syndrome
Hypoprolactinemia
Constitutional growth delay
Diabetes insipidus
Syndrome of inappropriate antidiuretic hormone secretion (SIADH)
Precocious puberty
Delayed puberty
Premature ovarian failure
Polycystic ovary syndrome
Androgen insensitivity syndrome
Kallmann syndrome
5-alpha-reductase deficiency
Autoimmune polyglandular syndrome type 1 (NORD)
Multiple endocrine neoplasia
Pancreatic neuroendocrine neoplasms
Zollinger-Ellison syndrome
Neuroendocrine tumors of the gastrointestinal system: Pathology review
Pheochromocytoma
Neuroblastoma
Opsoclonus myoclonus syndrome (NORD)
Adrenal insufficiency: Pathology review
Adrenal masses: Pathology review
Hyperthyroidism: Pathology review
Hypothyroidism: Pathology review
Thyroid nodules and thyroid cancer: Pathology review
Parathyroid disorders and calcium imbalance: Pathology review
Diabetes mellitus: Pathology review
Cushing syndrome and Cushing disease: Pathology review
Pituitary tumors: Pathology review
Hypopituitarism: Pathology review
Diabetes insipidus and SIADH: Pathology review
Multiple endocrine neoplasia: Pathology review
Hyperthyroidism medications
Hypothyroidism medications
Insulins
Hypoglycemics: Insulin secretagogues
Miscellaneous hypoglycemics
Adrenal hormone synthesis inhibitors
Mineralocorticoids and mineralocorticoid antagonists
Bones of the cranium
Anatomy of the cranial base
Anatomy of the orbit
Anatomy of the eye
Bones of the neck
Superficial structures of the neck: Cervical plexus
Superficial structures of the neck: Anterior triangle
Deep structures of the neck: Prevertebral muscles
Anatomy of the thyroid and parathyroid glands
Anatomy of the larynx and trachea
Anatomy of the pharynx and esophagus
Introduction to the cranial nerves
Anatomy of the olfactory (CN I) and optic (CN II) nerves
Anatomy of the oculomotor (CN III), trochlear (CN IV) and abducens (CN VI) nerves
Nasal cavity and larynx histology
Anatomy and physiology of the eye
Photoreception
Optic pathways and visual fields
Anatomy and physiology of the ear
Auditory transduction and pathways
Vestibular transduction
Vestibulo-ocular reflex and nystagmus
Olfactory transduction and pathways
Taste and the tongue
Glaucoma
Retinoblastoma
Laryngomalacia
Laryngitis
Bacterial epiglottitis
Eye conditions: Refractive errors, lens disorders and glaucoma: Pathology review
Eye conditions: Retinal disorders: Pathology review
Eye conditions: Inflammation, infections and trauma: Pathology review
Vertigo: Pathology review
Nasal, oral and pharyngeal diseases: Pathology review
Antihistamines for allergies
Acid reducing medications
Blood histology
Sepsis
Anaphylaxis
Food allergy
Blood products and transfusion: Clinical
Bites and stings: Clinical
Hematopoietic medications
Thrombolytics
Hemophilia
The nurse and doctor and the avoidable lawsuit (Coverys)
Traumatic brain injury: Pathology review
Concussion and traumatic brain injury
Traumatic brain injury: Clinical
Brain herniation
Drug administration and dosing regimens
Sympathomimetics: Direct agonists
Muscarinic antagonists
Cholinomimetics: Direct agonists
Cholinomimetics: Indirect agonists (anticholinesterases)
Anticonvulsants and anxiolytics: Barbiturates
Anticonvulsants and anxiolytics: Benzodiazepines
ACE inhibitors, ARBs and direct renin inhibitors
Thiazide and thiazide-like diuretics
Calcium channel blockers
Class I antiarrhythmics: Sodium channel blockers
Class II antiarrhythmics: Beta blockers
Class III antiarrhythmics: Potassium channel blockers
Class IV antiarrhythmics: Calcium channel blockers and others
Laxatives and cathartics
Antidiarrheals
Anticoagulants: Heparin
Anticoagulants: Warfarin
Anticoagulants: Direct factor inhibitors
Antiplatelet medications
Glucocorticoids
Opioid agonists, mixed agonist-antagonists and partial agonists
Nonbenzodiazepine anticonvulsants
Migraine medications
General anesthetics
Local anesthetics
Neuromuscular blockers
Opioid antagonists
Osmotic diuretics
Carbonic anhydrase inhibitors
Loop diuretics
Potassium sparing diuretics
PDE5 inhibitors
Estrogens and antiestrogens
Progestins and antiprogestins
Androgens and antiandrogens
Aromatase inhibitors
Uterine stimulants and relaxants
Bronchodilators: Beta 2-agonists and muscarinic antagonists
Bronchodilators: Leukotriene antagonists and methylxanthines

Transcript

Watch video only

On the Endocrinology ward, two people came in with similar symptoms. One of them is 45 year old Samantha, who complains of gaining a lot of weight lately. Samantha also suffers from severe asthma for which she’s taking oral glucocorticoids. She also had many viral and bacterial infections lately. On clinical examination, there’s truncal obesity, a large hump behind her neck, and striae on her abdomen. Her arterial pressure was elevated and she also had hyperglycemia. The other person is 38 year old Dan who is also obese, and has an abnormally round face. He has arterial hypertension and hyperglycemia. Unlike Samantha, Dan is not taking any medications. A 24 hour urine free cortisol was done in both individuals and levels were high. Further investigations were done, including ACTH levels.

Now, both individuals suffer from an endocrine disorder that involves high levels of cortisol. This is generally called Cushing syndrome. Now, if Cushing syndrome results from a pituitary adenoma making excess ACTH, it’s called Cushing disease.

Normally, the hypothalamus secretes corticotropin-releasing hormone, known as CRH,

which stimulates the pituitary gland to secrete adrenocorticotropic hormone, known as ACTH. ACTH travels to the adrenal glands where it targets cells in the adrenal cortex.

The adrenal cortex is the outer part of the adrenal gland and is subdivided into three layers-

the zona glomerulosa, the zona fasciculata, and the zona reticularis.

Zona fasciculata is the middle zone and also the widest zone, and ACTH specifically stimulates cells in this zone to secrete cortisol. This is a class of steroids, or lipid-soluble hormones, called glucocorticoids. Glucocorticoids are not soluble in water, so most cortisol in the blood is bound to a special carrier protein and only about 5% is unbound or free. In fact, only this small fraction of free cortisol is biologically active, and its levels are carefully controlled. Excess free cortisol is filtered in kidneys and dumped into the urine.

Free cortisol in the blood is involved in a number of things and it’s part of the circadian rhythm. Cortisol levels peak in the morning, when the body knows we need to “get up and go” and then drop in the evening, when we’re preparing for sleep. In times of stress, cortisol increases gluconeogenesis, proteolysis and lipolysis. Cortisol also helps maintain blood pressure by increasing the sensitivity of peripheral blood vessels to catecholamines, which further cause vasoconstriction. Cortisol helps to dampen the inflammatory and immune response by reducing the production and release of inflammatory mediators, as well as inhibiting the proliferation of T-lymphocytes. Finally, cortisol receptors are present in the brain, where their full effect is still actually unclear but might influence things like mood and memory.

For all this to work properly, though, the levels of free cortisol have to stay within the normal range.

To do that, the body uses negative feedback, which means that high levels of cortisol tell the hypothalamus and pituitary gland to decrease their secretion of CRH,

and ACTH, respectively. Less CRH also tells the pituitary to make less ACTH, so the pituitary ends up having two reasons not to make ACTH. With less ACTH floating around, the zona fasciculata gets less stimulation to make cortisol, and eventually, cortisol levels go back down to the normal range again.

Okay, now, Cushing syndrome can be caused by exogenous cortisol used as medications, or endogenous cortisol, meaning that the excess cortisol is made by the body.

A very high yield fact is that the majority of cases of Cushing syndrome occur in individuals using exogenous cortisol, like prednisone, over a long period of time, often as a treatment for autoimmune and inflammatory conditions, like rheumatoid arthritis or poorly controlled asthma. They have structures similar to endogenous cortisol and mimic its actions in various tissues.

In fact, exogenous cortisol can also cause negative feedback on the hypothalamus and the pituitary gland, leading to a decrease in CRH, and ACTH, which in turn, shuts down cortisol production from the zona fasciculata. Over time, this lack of stimulation can cause zona fasciculata of both adrenal glands to physically shrink or become atrophic. Even though this results in less endogenous cortisol production it still doesn’t quite compensate for the huge levels of exogenous cortisol, and that causes Cushing syndrome to develop.

Now, if the medication is stopped too abruptly, the atrophied adrenal glands can’t produce enough cortisol, so we get adrenal insufficiency. If the cortisol level is low enough, it might trigger an adrenal crisis. This is a life threatening condition with symptoms like fever, hypotension, severe abdominal pain with vomiting and diarrhea, confusion, psychosis, and coma.

In addition to taking exogenous steroid medications, Cushing syndrome can also result from increased levels of endogenous cortisol. The most common cause is Cushing disease where the pituitary releases too much ACTH. For your exams, remember the leading cause is a pituitary adenoma, which is a benign tumor of the pituitary gland. The exact reason for the development of this sort of benign tumor isn’t known, and the pituitary adenoma simply grows in size and secretes excess ACTH. This causes the zona fasciculata of both adrenal glands to undergo hyperplasia and secrete excess cortisol.

Apart from pituitary adenomas, there are ectopic sources of ACTH such as paraneoplastic syndromes. The high yield ones to remember are small cell lung cancer and bronchial carcinoids. In these cases, the excess ACTH is coming from somewhere other than the pituitary, so these cases are not considered Cushing disease.

Sources

  1. "Robbins Basic Pathology" Elsevier (2017)
  2. "Harrison's Principles of Internal Medicine, Twentieth Edition (Vol.1 & Vol.2)" McGraw-Hill Education / Medical (2018)
  3. "A Physiologic Approach to Diagnosis of the Cushing Syndrome" Annals of Internal Medicine (2003)
  4. "Cushing’s Syndrome: All Variants, Detection, and Treatment" Endocrinology and Metabolism Clinics of North America (2011)
  5. "Evaluation and treatment of Cushing’s syndrome" The American Journal of Medicine (2005)
  6. "Andrews' Diseases of the Skin: Clinical Dermatology ISBN 0-7216-2921-0" Saunders (2006-01-11)